ERBB2 and breast carcinoma: Breast cancer is one of the most frequent malignancies.236–241 A high level of GSDMB in breast cancers was related to tumor progression, and overexpression of GSDMB indicated a poor response to targeted treatment of HER-2.53 This means that GSDMB could be a novel prognostic marker for tumors.